Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,622 | 439 | 99.8% |
| Education | $11.79 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,074 | 84 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $608.45 | 26 | $0 (2024) |
| ABBVIE INC. | $606.63 | 44 | $0 (2024) |
| PFIZER INC. | $527.85 | 42 | $0 (2024) |
| Astellas Pharma US Inc | $306.82 | 18 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $269.82 | 17 | $0 (2024) |
| Allergan Inc. | $215.20 | 19 | $0 (2019) |
| Lilly USA, LLC | $189.84 | 13 | $0 (2024) |
| GlaxoSmithKline, LLC. | $180.62 | 14 | $0 (2022) |
| Amgen Inc. | $171.91 | 11 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,245 | 69 | PFIZER INC. ($225.77) |
| 2023 | $1,316 | 84 | AbbVie Inc. ($223.06) |
| 2022 | $747.13 | 42 | Amgen Inc. ($85.00) |
| 2021 | $421.13 | 30 | Takeda Pharmaceuticals U.S.A., Inc. ($85.97) |
| 2020 | $198.64 | 14 | AstraZeneca Pharmaceuticals LP ($49.56) |
| 2019 | $690.25 | 51 | Novo Nordisk Inc ($167.01) |
| 2018 | $811.30 | 55 | Novo Nordisk Inc ($204.05) |
| 2017 | $1,204 | 97 | Novo Nordisk Inc ($281.07) |
All Payment Transactions
442 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/28/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: PAIN | ||||||
| 10/24/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Cardio-renal | ||||||
| 10/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: DIABETES | ||||||
| 10/14/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: Endocrinology | ||||||
| 10/03/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/27/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 09/25/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $6.77 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $12.34 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: Respiratory | ||||||
| 09/12/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Diabetes | ||||||
| 09/11/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart, Flector | Food and Beverage | Cash or cash equivalent | $16.47 | General |
| Category: Endocrinology | ||||||
| 09/07/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Biological | ||||||
| 08/27/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: NEUROSCIENCE | ||||||
| 08/07/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: PAIN | ||||||
| 08/05/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: Obesity | ||||||
| 08/02/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: Respiratory | ||||||
| 08/02/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.15 | General |
| Category: NEUROSCIENCE | ||||||
| 07/29/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/25/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: NEUROSCIENCE | ||||||
| 07/24/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: Respiratory | ||||||
| 07/22/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Oncology | ||||||
| 07/18/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: Diabetes | ||||||
| 07/15/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: Biological | ||||||
| 07/11/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 809 | 1,211 | $148,629 | $69,245 |
| 2022 | 16 | 878 | 1,342 | $157,645 | $75,090 |
| 2021 | 20 | 939 | 1,377 | $185,277 | $85,717 |
| 2020 | 18 | 906 | 1,378 | $198,474 | $82,401 |
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 128 | 261 | $50,895 | $22,058 | 43.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 136 | 136 | $28,560 | $16,887 | 59.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 140 | 273 | $36,036 | $14,913 | 41.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 59 | 105 | $7,875 | $4,005 | 50.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 25 | 30 | $7,800 | $4,001 | 51.3% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 128 | 128 | $4,480 | $2,236 | 49.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 56 | 71 | $5,680 | $2,144 | 37.7% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 28 | 32 | $2,400 | $1,257 | 52.4% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 11 | 27 | $2,025 | $675.37 | 33.4% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 37 | 68 | $2,108 | $647.36 | 30.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 42 | 50 | $410.00 | $357.00 | 87.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 19 | 30 | $360.00 | $63.80 | 17.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 161 | 387 | $51,084 | $22,213 | 43.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 146 | 146 | $30,660 | $18,680 | 60.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 80 | 136 | $26,520 | $12,104 | 45.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 67 | 121 | $9,075 | $4,552 | 50.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 82 | 115 | $9,200 | $3,806 | 41.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 18 | 50 | $7,000 | $2,836 | 40.5% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 11 | 13 | $5,460 | $2,821 | 51.7% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 133 | 133 | $4,655 | $2,359 | 50.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 15 | 15 | $3,900 | $2,039 | 52.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 11 | 11 | $2,310 | $913.36 | 39.5% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 47 | 94 | $2,914 | $901.82 | 30.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 12 | 12 | $1,680 | $623.10 | 37.1% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 16 | 17 | $1,700 | $533.76 | 31.4% |
About Dr. David Scoggin, M.D
Dr. David Scoggin, M.D is a Family Medicine healthcare provider based in Lancaster, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1891766259.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Scoggin, M.D has received a total of $6,633 in payments from pharmaceutical and medical device companies, with $1,245 received in 2024. These payments were reported across 442 transactions from 59 companies. The most common payment nature is "Food and Beverage" ($6,622).
As a Medicare-enrolled provider, Scoggin has provided services to 3,532 Medicare beneficiaries, totaling 5,308 services with total Medicare billing of $312,453. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Lancaster, OH
- Active Since 02/01/2006
- Last Updated 02/19/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1891766259
Products in Payments
- FARXIGA (Drug) $313.83
- Victoza (Drug) $288.31
- Ozempic (Drug) $263.26
- UBRELVY (Drug) $248.19
- ELIQUIS (Drug) $216.84
- REXULTI (Drug) $205.79
- VRAYLAR (Drug) $177.67
- Kerendia (Drug) $149.57
- NURTEC ODT (Drug) $145.34
- JARDIANCE (Drug) $138.88
- Veozah (Drug) $136.66
- Wegovy (Drug) $132.41
- Aimovig (Biological) $129.19
- LINZESS (Drug) $126.93
- Dexcom G6 Transmitter (Medical Supply) $121.91
- Vascepa (Drug) $121.31
- APTIOM (Drug) $112.56
- NUEDEXTA (Drug) $112.48
- Tresiba (Drug) $112.44
- SYMBICORT (Drug) $107.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Lancaster
Dr. Stephen Gold, D.o, D.O
Family Medicine — Payments: $78,584
Dr. Michael Steelman, D.o, D.O
Family Medicine — Payments: $58,078
Dr. Stephen Diamantoni, M.d, M.D
Family Medicine — Payments: $23,670
Ruben Hernandez, Md, MD
Family Medicine — Payments: $19,567
Ryan Dammerman, Md, MD
Family Medicine — Payments: $11,706
Troy Hampton, D.o, D.O
Family Medicine — Payments: $10,969